Evidence map›Paper›PMID 25486068›Full record

ArticlePloS one2014

Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.

Vanessa Nienhouse, Xiang Gao, Qunfeng Dong, David E Nelson, Evelyn Toh, Kathleen McKinley, Paul Schreckenberger, Noriko Shibata, Cynthia S Fok, Elizabeth R Mueller and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 114 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Current infectious disease reports · 2023
    Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Vanessa NienhouseThe Burn and Shock Trauma Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Microbiology and Immunology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Stritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Infectious Disease and Immunology Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Xiang GaoDepartment of Biological Sciences, University of North Texas, Denton, Texas, United States of America; Department of Computer Science and Engineering, University of North Texas, Denton, Texas, United States of America.
Qunfeng DongDepartment of Biological Sciences, University of North Texas, Denton, Texas, United States of America; Department of Computer Science and Engineering, University of North Texas, Denton, Texas, United States of America.
David E NelsonDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Evelyn TohDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Kathleen McKinleyDepartment of Pathology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Paul SchreckenbergerStritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Infectious Disease and Immunology Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Pathology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Noriko ShibataDepartment of Microbiology and Immunology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Infectious Disease and Immunology Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Cynthia S FokStritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Obstetrics/Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Urology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Elizabeth R MuellerStritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Obstetrics/Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Urology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Linda BrubakerStritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Obstetrics/Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Urology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Alan J WolfeDepartment of Microbiology and Immunology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Stritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Infectious Disease and Immunology Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Katherine A RadekThe Burn and Shock Trauma Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Microbiology and Immunology at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Stritch School of Medicine at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Infectious Disease and Immunology Research Institute at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America; Department of Surgery at Loyola University Chicago, Health Sciences Division, Maywood, Illinois, United States of America.
Loyola University Chicago · USIndiana University School of MedicineUniversity of North Texas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resident bacterial communities (microbiota) and host antimicrobial peptides (AMPs) are both essential components of normal host innate immune responses that limit infection and pathogen induced inflammation. However, their interdependence has not been investigated in the context of urinary tract infection (UTI) susceptibility. Here, we explored the interrelationship between the urinary microbiota and host AMP responses as mechanisms for UTI risk. Using prospectively collected day of surgery (DOS) urine specimens from female pelvic floor surgery participants, we report that the relative abundance and/or frequency of specific urinary microbiota distinguished between participants who did or did not develop a post-operative UTI. Furthermore, UTI risk significantly correlated with both specific urinary microbiota and β-defensin AMP levels. Finally, urinary AMP hydrophobicity and protease activity were greater in participants who developed UTI, and correlated positively with both UTI risk and pelvic floor symptoms. These data demonstrate an interdependency between the urinary microbiota, AMP responses and symptoms, and identify a potential mechanism for UTI risk. Assessment of bacterial microbiota and host innate immune AMP responses in parallel may identify increased risk of UTI in certain populations.

Indexed as

MicrobiotaAdenosine MonophosphateAnti-Infective AgentsAntimicrobial Cationic PeptidesBacteriabeta-DefensinsBiodiversityCohort StudiesEnzyme ActivationFemaleHumansHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsPeptide HydrolasesPhylogenyRisk FactorsAdenosine MonophosphateAnti-Infective AgentsAntimicrobial Cationic Peptidesbeta-DefensinsDEFB1 protein, humanPeptide Hydrolases

Identifiers

PMID25486068
PMCPMC4259481
OpenAlexW1972126171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.